31 min listen
ratings:
Length:
23 minutes
Released:
Apr 5, 2019
Format:
Podcast episode
Description
We tackle a listener question on today's show -- why should I care about EBITDA? Listen in to get a breakdown of the metric, how it can be used for good, and how it can be abused by businesses trying to mask bad results. Check out more of our content here: TMF's podcast portal YouTube Twitter Join Our Motley Fool Podcast Facebook Group LinkedIn StockUp, The Motley Fool's weekly email newsletter
Released:
Apr 5, 2019
Format:
Podcast episode
Titles in the series (100)
Healthcare: 3 Beaten-Up Biotechs -- Are They Buys?: Here's why post-approval setbacks have caused Puma Biotechnology, Clovis Oncology, and Regenxbio shares to tumble, and if any of these stocks are finally worth buying. Stocks: PBYI, CLVS, RGNX Check out more of our content here: by Industry Focus